Nadia Danon1,2, Muaamar Al-Gobari2,3, Bernard Burnand2, Pierre-Yves Rodondi2,3. 1. Pain Center and Center for Integrative and Complementary Medicine, Department of Anesthesiology, Lausanne University Hospital and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. 2. Center for Primary Care and Public Health (Unisanté) and Cochrane Switzerland, University of Lausanne, Lausanne, Switzerland. 3. Institute of Family Medicine, University of Fribourg, Fribourg, Switzerland.
Abstract
OBJECTIVE: To assess whether mind-body therapies are effective for relieving cancer-related pain in adults, since at least one-third of adults with cancer are affected by moderate or severe pain. METHODS: We searched for all randomized or quasi-randomized controlled trials that included adults (≥18 years) with cancer-related pain who were treated with mind-body therapies (mindfulness, hypnosis, yoga, guided imagery, and progressive muscle relaxation) in MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), Science Citation Index, Web of Science, trials registers, and reference lists. The primary outcome was pain intensity. We calculated the standardized mean differences and 95% confidence intervals (CIs) and assessed the risk of bias. RESULTS: We identified 40 primary studies involving a total of 3569 participants. The meta-analysis included 24 studies (2404 participants) and showed a significant effect of -0.39 (95% CI -0.62 to -0.16) with considerable heterogeneity (I2 = 86.3%, p < 0.001). After we excluded four "outlier" studies in sensitivity analyses, the effect size remained significant but weaker. There was a high risk of bias in all studies, for example, performance bias due to lack of participant blinding. Patients in multiple settings were included but many studies were of low quality. CONCLUSIONS: Mind-body therapies may be effective in improving cancer pain, but the quality of the evidence is low. There is a need for further high-quality clinical trials.
OBJECTIVE: To assess whether mind-body therapies are effective for relieving cancer-related pain in adults, since at least one-third of adults with cancer are affected by moderate or severe pain. METHODS: We searched for all randomized or quasi-randomized controlled trials that included adults (≥18 years) with cancer-related pain who were treated with mind-body therapies (mindfulness, hypnosis, yoga, guided imagery, and progressive muscle relaxation) in MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), Science Citation Index, Web of Science, trials registers, and reference lists. The primary outcome was pain intensity. We calculated the standardized mean differences and 95% confidence intervals (CIs) and assessed the risk of bias. RESULTS: We identified 40 primary studies involving a total of 3569 participants. The meta-analysis included 24 studies (2404 participants) and showed a significant effect of -0.39 (95% CI -0.62 to -0.16) with considerable heterogeneity (I2 = 86.3%, p < 0.001). After we excluded four "outlier" studies in sensitivity analyses, the effect size remained significant but weaker. There was a high risk of bias in all studies, for example, performance bias due to lack of participant blinding. Patients in multiple settings were included but many studies were of low quality. CONCLUSIONS: Mind-body therapies may be effective in improving cancer pain, but the quality of the evidence is low. There is a need for further high-quality clinical trials.
Authors: Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Karen O Anderson; Marlene Z Cohen; Tito R Mendoza; Hong Guo; Margaret T Harle; Charles S Cleeland Journal: Cancer Date: 2006-07-01 Impact factor: 6.860
Authors: Sherri Sheinfeld Gorin; Paul Krebs; Hoda Badr; Elizabeth Amy Janke; Heather S L Jim; Bonnie Spring; David C Mohr; Mark A Berendsen; Paul B Jacobsen Journal: J Clin Oncol Date: 2012-01-17 Impact factor: 44.544
Authors: S Hosakote Vadiraja; M Raghavendra Rao; R Hongasandra Nagendra; Raghuram Nagarathna; Mohan Rekha; Nanjundiah Vanitha; S Kodaganuru Gopinath; Bs Srinath; Ms Vishweshwara; Ys Madhavi; Basavalingaiah S Ajaikumar; S Bilimagga Ramesh; Nalini Rao Journal: Int J Yoga Date: 2009-07
Authors: Marieke H J van den Beuken-van Everdingen; Laura M J Hochstenbach; Elbert A J Joosten; Vivianne C G Tjan-Heijnen; Daisy J A Janssen Journal: J Pain Symptom Manage Date: 2016-04-23 Impact factor: 3.612
Authors: Clare Rayment; Marianne J Hjermstad; Nina Aass; Stein Kaasa; Augusto Caraceni; Florian Strasser; Ellen Heitzer; Robin Fainsinger; Michael I Bennett Journal: Palliat Med Date: 2012-11-21 Impact factor: 4.762
Authors: Désirée Lötzke; Florian Wiedemann; Daniela Rodrigues Recchia; Thomas Ostermann; Daniel Sattler; Johannes Ettl; Marion Kiechle; Arndt Büssing Journal: Evid Based Complement Alternat Med Date: 2016-02-25 Impact factor: 2.629